Business Description
Zhejiang Wecome Pharmaceutical Co Ltd
ISIN : CNE1000047P9
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.91 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.27 | |||||
Debt-to-EBITDA | -7.15 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 3.59 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC |
Growth Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -9.1 | |||||
3-Year EBITDA Growth Rate | -35.7 | |||||
3-Year FCF Growth Rate | 12.7 | |||||
3-Year Book Growth Rate | 0.2 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 93.02 | |||||
9-Day RSI | 82.66 | |||||
14-Day RSI | 73.88 | |||||
6-1 Month Momentum % | -22.81 | |||||
12-1 Month Momentum % | -38.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.46 | |||||
Quick Ratio | 3.69 | |||||
Cash Ratio | 1.82 | |||||
Days Inventory | 198.13 | |||||
Days Sales Outstanding | 205.33 | |||||
Days Payable | 117.91 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.43 | |||||
Forward Dividend Yield % | 1.43 | |||||
5-Year Yield-on-Cost % | 1.43 | |||||
Shareholder Yield % | -0.63 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.82 | |||||
Operating Margin % | -12.87 | |||||
Net Margin % | -11.69 | |||||
FCF Margin % | -24.01 | |||||
ROE % | -4.17 | |||||
ROA % | -3 | |||||
ROIC % | -3.97 | |||||
3-Year ROIIC % | -36.2 | |||||
ROC (Joel Greenblatt) % | -3.97 | |||||
ROCE % | -3.02 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shiller PE Ratio | 24.18 | |||||
PS Ratio | 4.65 | |||||
PB Ratio | 1.91 | |||||
Price-to-Tangible-Book | 2.01 | |||||
Price-to-Operating-Cash-Flow | 669.61 | |||||
EV-to-EBIT | -45.5 | |||||
EV-to-EBITDA | -45.5 | |||||
EV-to-Revenue | 4.5 | |||||
EV-to-FCF | -18.74 | |||||
Price-to-Projected-FCF | 10.55 | |||||
Price-to-Net-Current-Asset-Value | 9.57 | |||||
Earnings Yield (Greenblatt) % | -2.2 | |||||
FCF Yield % | -4.76 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Zhejiang Wecome Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 500.17 | ||
EPS (TTM) (Â¥) | -0.41 | ||
Beta | 0.97 | ||
Volatility % | 40.84 | ||
14-Day RSI | 73.88 | ||
14-Day ATR (Â¥) | 0.733902 | ||
20-Day SMA (Â¥) | 14.4805 | ||
12-1 Month Momentum % | -38.67 | ||
52-Week Range (Â¥) | 13.31 - 38.23 | ||
Shares Outstanding (Mil) | 144.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Zhejiang Wecome Pharmaceutical Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Zhejiang Wecome Pharmaceutical Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Zhejiang Wecome Pharmaceutical Co Ltd Frequently Asked Questions
What is Zhejiang Wecome Pharmaceutical Co Ltd(SZSE:300878)'s stock price today?
When is next earnings date of Zhejiang Wecome Pharmaceutical Co Ltd(SZSE:300878)?
Does Zhejiang Wecome Pharmaceutical Co Ltd(SZSE:300878) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |